Cargando…

Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy

Pulmonary arterial hypertension (PAH) is a progressive and debilitating condition. Despite promoting vasodilation, current drugs have a therapeutic window within which they are limited by systemic side effects. Nanomedicine uses nanoparticles to improve drug delivery and/or reduce side effects. We h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed, Nura A., Davies, Robert P., Lickiss, Paul D., Ahmetaj-Shala, Blerina, Reed, Daniel M., Gashaw, Hime H., Saleem, Hira, Freeman, Gemma R., George, Peter M., Wort, Stephen J., Morales-Cano, Daniel, Barreira, Bianca, Tetley, Teresa D., Chester, Adrian H., Yacoub, Magdi H., Kirkby, Nicholas S., Moreno, Laura, Mitchell, Jane A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841901/ https://www.ncbi.nlm.nih.gov/pubmed/28447910 http://dx.doi.org/10.1177/2045893217710224

Ejemplares similares

A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension
por: Mohamed, Nura A., et al.
Publicado: (2016)

Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension
por: Mohamed, Nura A., et al.
Publicado: (2021)

Role of prostacyclin in pulmonary hypertension
por: Mitchell, Jane A., et al.
Publicado: (2014)

Activation and Contraction of Human “Vascular” Smooth Muscle Cells Grown From Circulating Blood Progenitors
por: Ahmetaj-Shala, Blerina, et al.
Publicado: (2021)

Ibuprofen arginate retains eNOS substrate activity and reverses endothelial dysfunction: implications for the COX-2/ADMA axis
por: Kirkby, Nicholas S., et al.
Publicado: (2016)

The role of endothelin-1 in pulmonary arterial hypertension
por: Chester, Adrian H., et al.
Publicado: (2014)

Nitric oxide and pulmonary arterial hypertension
por: Chester, Adrian H., et al.
Publicado: (2017)

Metabolomic profiling of amines in sepsis predicts changes in NOS canonical pathways
por: Tesfai, Abel, et al.
Publicado: (2017)

Cardiorenal Tissues Express SARS-CoV-2 Entry Genes and Basigin (BSG/CD147) Increases With Age in Endothelial Cells
por: Ahmetaj-Shala, Blerina, et al.
Publicado: (2020)

Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for in- stent thrombosis in diabetes
por: Marei, Isra, et al.
Publicado: (2022)

A bioassay system of autologous human endothelial, smooth muscle cells, and leukocytes for use in drug discovery, phenotyping, and tissue engineering
por: Ahmetaj‐Shala, Blerina, et al.
Publicado: (2019)

Incidence of haematological malignancies in Kosovo—A post "uranium war" concern
por: Latifi-Pupovci, Hatixhe, et al.
Publicado: (2020)

Tipifarnib prevents development of hypoxia-induced pulmonary hypertension
por: Duluc, Lucie, et al.
Publicado: (2017)

Chronic thromboembolic pulmonary hypertension – still evolving
por: Gerges, Mario, et al.
Publicado: (2020)

Severe degeneration of a sub-coronary pulmonary autograft in a young adult
por: Latif, Najma, et al.
Publicado: (2021)

Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease
por: Thorley, Andrew J, et al.
Publicado: (2007)

Cyclooxygenase-2 Selectively Controls Renal Blood Flow Through a Novel PPARβ/δ-Dependent Vasodilator Pathway
por: Kirkby, Nicholas S., et al.
Publicado: (2018)

Upregulated Genes In Sporadic, Idiopathic Pulmonary Arterial Hypertension
por: Edgar, Alasdair J, et al.
Publicado: (2006)

Biomarkers of Inflammation among Patients with COVID-19: A Single-Centre Prospective Study from Prishtina, Kosovo
por: Latifi-Pupovci, Hatixhe, et al.
Publicado: (2022)

Three-dimensional images of a pulmonary dominant truncus arteriosus before and after a novel repair
por: Nagy, Mohamed, et al.
Publicado: (2021)

Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients
por: Latifi-Pupovci, Hatixhe, et al.
Publicado: (2022)

Effect of Side-Specific Valvular Shear Stress on the Content of Extracellular Matrix in Aortic Valves
por: Mongkoldhumrongkul, Napachanok, et al.
Publicado: (2016)

Role of hypoxia inducible factor HIF-1α in heart valves
por: Georgy, Mark, et al.
Publicado: (2023)

Primary Pulmonary Hypertension: Pathologist as Patient
por: Polak, Julia A, et al.
Publicado: (1998)

Development of a novel UHPLC-MS/MS-based platform to quantify amines, amino acids and methylarginines for applications in human disease phenotyping
por: Ahmetaj-Shala, Blerina, et al.
Publicado: (2018)

Astragaloside II promotes intestinal epithelial repair by enhancing L-arginine uptake and activating the mTOR pathway
por: Lee, Shih-Yu, et al.
Publicado: (2017)

Organ Culture Model of Aortic Valve Calcification
por: Chester, Adrian H., et al.
Publicado: (2021)

Valvulogenesis of a living, innervated pulmonary root induced by an acellular scaffold
por: Yacoub, Magdi H., et al.
Publicado: (2023)

Tumoral pulmonary hypertension
por: Price, Laura C., et al.
Publicado: (2019)

Antegrade flow in Anomalous Left Coronary Artery from Pulmonary Artery: Clinical implications
por: Sedky, Yasser, et al.
Publicado: (2014)

Quantitative assessment of right ventricular structure and flow dynamics in pulmonary homograft obstruction
por: Chapron, Julien, et al.
Publicado: (2014)

Atypical Expression of Smooth Muscle Markers and Co-activators and Their Regulation in Rheumatic Aortic and Calcified Bicuspid Valves
por: Latif, Najma, et al.
Publicado: (2022)

Pulmonary hypertension in the developing world: Local registries, challenges, and ways to move forward
por: Idrees, Majdy, et al.
Publicado: (2020)

The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension
por: Harrington, Louise S., et al.
Publicado: (2010)

Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension
por: Morales-Cano, Daniel, et al.
Publicado: (2021)

Evidence That Links Loss of Cyclooxygenase-2 With Increased Asymmetric Dimethylarginine: Novel Explanation of Cardiovascular Side Effects Associated With Anti-Inflammatory Drugs
por: Ahmetaj-Shala, Blerina, et al.
Publicado: (2015)

Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis
por: Kirkby, Nicholas S, et al.
Publicado: (2019)

Pulmonary artery banding in a modified Mustard operation improves biventricular geometry and function
por: Hosny, Hatem, et al.
Publicado: (2020)

Progress in the understanding and management of pulmonary arterial hypertension
por: Chakrabarti, A.M., et al.
Publicado: (2015)

The living aortic valve: From molecules to function
por: Chester, Adrian H., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_84v6fhijbocqknf9on0gsl0qeo